We are extremely pleased to announce our Metro North Clinician Research Fellows for 2021
The 2021 Fellows at the Fellows Welcome Breakfast hosted by Shaun Drummond, Feb 2021. (L-R) Lata Vadlamudi, Victoria Eley, Natasha Roberts, Dylan Flaws, Thuy Frakking
Associate Professor Victoria Eley, Demonstrating the effect of pre-delivery antibiotics on the neonatal intestinal microbiome and immune system
Anaesthesia and Perioperative Medicine, The Royal Brisbane and Women’s Hospital
Victoria will use her Fellowship to optimise clinical outcomes for mother and child following a caesarean section by determining if pre-incisional antibiotics administered to the mother at caesarean section increases childhood allergic disease.
Ms Natasha Roberts, Addressing unmet needs in prostate cancer care
Cancer Care Services, The Royal Brisbane and Women’s Hospital
Natasha will lead a body of research to understand and address unmet needs in prostate cancer care through a collaborative, quality and clinically based program of research that improves the support and outcomes for men with prostate cancer.
Associate Professor Dylan Flaws, Greater recovery after critical care (GRACE)
Mental Health, Caboolture Hospital
Dylan will pioneer a new understanding of post intensive care syndrome and transform patient lives through improving the services provided after severe illness, allowing them to function independently, return to work and remain out of hospital.
Dr Thuy Frakking, Standardisation of swallowing sounds to provide better access to safer, more accurate and improved reliability for the detection of swallowing disorders in neonates and children
Research Development Unit, Caboolture Hospital
Thuy will develop an accessible gold standard test for the assessment and diagnosis of swallowing disorders to improve the health, social and economic outcomes in neonates and children.
Associate Professor Lata Vadlamudi, Developing a Queensland neuro-genomics service to underpin the era of precision-based medicine
Neurology, The Royal Brisbane and Women’s Hospital
Lata will apply genomics to improve diagnoses and personalise treatment for patients, in developing a patient-specific, in vitro drug screening platform for drug-resistant epilepsy patients.